RadNet (RDNT) Digital Health CEO granted 20,330 common shares

Rhea-AI Filing Summary

RadNet, Inc. reported that Cornelis Wesdorp, Pres & CEO, Digital Health, received a grant of 20,330 shares of Common Stock as of March 3, 2026. The transaction was recorded at a price of $0.0000 per share and classified as a grant, award, or other acquisition.

Following this award, Wesdorp held a total of 73,825 shares of RadNet common stock in direct ownership, as disclosed in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wesdorp Cornelis

(Last) (First) (Middle)

C/O RADNET, INC.

1510 COTNER AVENUE

(Street)

LOS ANGELES CA 90025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RadNet, Inc. [ RDNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres & CEO, Digital Health

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		20,330	A	$0	73,825	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jose Gamez, Attorney-in-Fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did RadNet (RDNT) report for Cornelis Wesdorp?

RadNet reported that Cornelis Wesdorp received a grant of 20,330 shares of Common Stock. The transaction occurred on March 3, 2026 and was classified as a grant, award, or other acquisition, increasing his directly held RadNet shares to 73,825 after the transaction.

How many RadNet (RDNT) shares were granted to Cornelis Wesdorp?

Cornelis Wesdorp was granted 20,330 shares of RadNet Common Stock. This award was recorded in a Form 4 insider filing and is described as a grant, award, or other acquisition, contributing to a post-transaction total direct ownership position of 73,825 common shares.

What is Cornelis Wesdorp’s RadNet (RDNT) shareholding after this Form 4 grant?

After the reported grant, Cornelis Wesdorp directly held 73,825 shares of RadNet Common Stock. This total reflects the addition of 20,330 shares from the March 3, 2026 grant, which the Form 4 classifies as a grant, award, or other acquisition transaction.

At what price was the RadNet (RDNT) stock grant to Cornelis Wesdorp recorded?

The 20,330-share grant of RadNet Common Stock to Cornelis Wesdorp was recorded at a transaction price of $0.0000 per share. This price is disclosed in the Form 4 filing, which describes the transaction as a grant, award, or other acquisition of common shares.

What role does Cornelis Wesdorp hold at RadNet (RDNT) in this insider filing?

In this insider filing, Cornelis Wesdorp is identified as Pres & CEO, Digital Health of RadNet, Inc. The Form 4 associates his officer position with the reported grant of 20,330 Common Stock shares, which increased his directly owned stake to 73,825 shares.